Nadph oxidases connecting fatty liver disease, insulin resistance and type 2 diabetes: current knowledge and therapeutic outlook

HIGHLIGHTS

• who: Alberto Nascè and colleagues from the Service of Endocrinology, Diabetes, Nutrition and Patient Education, Geneva University Hospitals, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland have published the paper: NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook, in the Journal: Antioxidants of 14/04/2022
• what: The differentiation of Th17 and Treg cells has been linked to cellular ROS levels, although until now studies aiming to uncover the exact mechanism of action have yielded diverging results . Due to the lack of obvious . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.